Members of Orrick's Financial & Fintech Advisory practice and government agency representatives and regulators will discuss important updates on government lending at Mortgage Bankers Association Compliance.

Members of Orrick's Financial & Fintech Advisory practice join other thought leaders at the Mortgage Bankers Association Legal Issues and Regulatory Compliance Conference to discuss critical topics facing legal and compliance professionals across the mortgage industry.

Orrick is proud to sponsor the Mortgage Banker Association's brand-new Compliance and Risk Management Conference.

Steve vonBerg will discuss "Renewed Interest in Mortgage Assumptions in a Rising Interest Rate Environment: What was Yours is Now Mine" and Max Bonici will discuss "Enforcement Risk and Trends for Crypto and Digital Assets (Part 2)."

Steve vonBerg joined a panel to discuss what mortgage executives are thinking, issues they are working through, and best practices for navigating 2023.

Orrick attorneys discuss concerns around data protection and privacy, best practices for state licensing challenges, insights on legislation and requirements, recent fair lending cases, and more.

Steven vonBerg joined a panel of industry experts to discuss regulatory concerns, including updates on FHFA’s scaling back of second home and investment property mortgages, CFPB priorities, the CDFI no-doc loan program, and fair lending issues.

Orrick attorneys discussed the latest updates and topics at the May 2022 Mortgage Bankers Association Legal Issues and Regulatory Compliance Conference.

Steven R. vonBerg discussed the latest on the political football of the new administration, QM rule cancellation & their implications.

Jeff Naimon provided an analysis of the expected key regulatory changes to come, and Steven R. vonBerg discussed loan originator compensation and provide his thoughts on common compliance challenges.

Steven vonBerg discussed the current state of the non-QM market as well as the impact of new QM rules, and Jeffrey Naimon discussed non-QM post-Covid.